Showing 3,441 - 3,460 results of 18,314 for search 'significantly ((((((a decrease) OR (largest decrease))) OR (mean decrease))) OR (nn decrease))', query time: 0.48s Refine Results
  1. 3441

    GLM models for predictors of monthly HIV costs. by Drew B. Cameron (10687420)

    Published 2024
    “…<div><p>Background</p><p>Despite improvements to the cascade of HIV care in East Africa, access to care for non-communicable disease co-morbidities like hypertension (HTN) remains a persistent problem. The integration of care for these conditions presents an opportunity to achieve efficiencies in delivery as well as decrease overall costs for patients. …”
  2. 3442

    Median cost (USD) per visit breakdown. by Drew B. Cameron (10687420)

    Published 2024
    “…<div><p>Background</p><p>Despite improvements to the cascade of HIV care in East Africa, access to care for non-communicable disease co-morbidities like hypertension (HTN) remains a persistent problem. The integration of care for these conditions presents an opportunity to achieve efficiencies in delivery as well as decrease overall costs for patients. …”
  3. 3443
  4. 3444
  5. 3445
  6. 3446
  7. 3447
  8. 3448
  9. 3449
  10. 3450
  11. 3451
  12. 3452
  13. 3453
  14. 3454
  15. 3455
  16. 3456

    Table 1_Imeglimin may affect hemoglobin A1c accuracy via prolongation of erythrocyte lifespan in patients with type 2 diabetes mellitus: insights from the INFINITY clinical trial.d... by Takeshi Osonoi (1951555)

    Published 2025
    “…While HbA1c and GA decreased and 1,5-AG increased one month after imeglimin initiation, GA and 1,5-AG showed rapid changes compared to the gradual decrease in HbA1c. …”
  17. 3457
  18. 3458
  19. 3459

    Table 1_Atractylenolide-I restore intestinal barrier function by targeting the S100A9/AMPK/mTOR signaling pathway.xlsx by Chen Chen (6544)

    Published 2025
    “…Transcriptomic analysis revealed that AT-1 significantly modulated the expression of S100A8 and S100A9. …”
  20. 3460

    Image 2_Atractylenolide-I restore intestinal barrier function by targeting the S100A9/AMPK/mTOR signaling pathway.tif by Chen Chen (6544)

    Published 2025
    “…Transcriptomic analysis revealed that AT-1 significantly modulated the expression of S100A8 and S100A9. …”